CLINICAL_TRIALS
trial_result
· 2018-05-07
Clinical Trial Update: Enzalutamide for Bladder Cancer Chemoprevention [Phase 2]
Summary
Phase 2 trial update for enzalutamide as a chemoprevention strategy in bladder cancer has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Rochester | Conditions: Bladder Cancer | Phase 2 | Status: TERMINATED | Results posted: 2018-05-07